Quantitative proteomics in cardiovascular research: Global and targeted strategies

Proteomics - Clinical Applications

Volumn 8, Issue 7-8, 2014, Pages 488-505

  Shen, Xiaomeng ^a   Young, Rebeccah ^a   Canty, John M ^a,b   Qu, Jun ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biomarker; Cardiovascular diseases; LC MS; Mechanism study; Targeted quantification

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

CARDIOVASCULAR DISEASE; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; ION CURRENT; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL RESEARCH; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROCESS MONITORING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; QUANTITATIVE PROTEOMICS; REVIEW; SELECTED REACTION MONITORING; SPECTRAL COUNTING; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; PROTEOMICS;

EID: 84906076366     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400014     Document Type: Review

References (160)

1. Yusuf, S., Reddy, S., Ounpuu, S., Anand, S., Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001, 104, 2855-2864.
2. Cui, Z., Dewey, S., Gomes, A. V., Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases. Am. J. Cardiovasc. Dis. 2011, 1, 274-292.
3. Arab, S., Gramolini, A. O., Ping, P., Kislinger, T. et al., Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J. Am. Coll. Cardiol. 2006, 48, 1733-1741.
4. Hoofnagle, A. N., Wener, M. H., The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Met. 2009, 347, 3-11.
5. Schnabel, R. B., Baccarelli, A., Lin, H., Ellinor, P. T., Benjamin, E. J., Next steps in cardiovascular disease genomic research-sequencing, epigenetics, and transcriptomics. Clin. Chem. 2012, 58, 113-126.
6. Rugg-Gunn, P. J., Cox, B. J., Lanner, F., Sharma, P. et al., Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Dev. Cell. 2012, 22, 887-901.
7. Cox, B., Kotlyar, M., Evangelou, A. I., Ignatchenko, V. et al., Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol. Syst. Biol. 2009, 5, 279.
8. Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I. et al., Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6, 450.
9. Mallick, P., Kuster, B., Proteomics: a pragmatic perspective. Nat. Biotechnol. 2010, 28, 695-709.
10. de Godoy, L. M., Olsen, J. V., Cox, J., Nielsen, M. L. et al., Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 2008, 455, 1251-1254.
11. Azimzadeh, O., Sievert, W., Sarioglu, H., Yentrapalli, R. et al., PPAR alpha: a novel radiation target in locally exposed Mus musculus heart revealed by quantitative proteomics. J. Proteome Res. 2013, 12, 2700-2714.
12. Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M. et al., A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419, 520-526.
13. Rabilloud, T., Chevallet, M., Luche, S., Lelong, C., Two-dimensional gel electrophoresis in proteomics: past, present and future. J. Proteomics 2010, 73, 2064-2077.
14. Van Eyk, J. E., Overview: the maturing of proteomics in cardiovascular research. Circ. Res. 2011, 108, 490-498.
15. Sharma, P., Cosme, J., Gramolini, A. O., Recent advances in cardiovascular proteomics. J. Proteomics 2013, 81, 3-14.
16. Page, B., Young, R., Iyer, V., Suzuki, G. et al., Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ. Res. 2008, 102, 103-112.
17. Banfi, C., Brioschi, M., Tremoli, E., Cardiovascular proteomics: challenges and opportunities for cardiologists of the future. G. Ital. Cardiol. 2013, 14, 495-503.
18. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
19. Dayon, L., Hainard, A., Licker, V., Turck, N. et al., Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal. Chem. 2008, 80, 2921-2931.
20. Rauniyar, N., Gao, B., McClatchy, D. B., Yates, J. R., 3rd, Comparison of protein expression ratios observed by sixplex and duplex TMT labeling method. J. Proteome Res. 2013, 12, 1031-1039.
21. Hebert, A. S., Merrill, A. E., Bailey, D. J., Still, A. J. et al., Neutron-encoded mass signatures for multiplexed proteome quantification. Nat. Methods 2013, 10, 332-334.
22. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
23. Lengqvist, J., Sandberg, A., Stable isotope labeling methods in protein profiling. Methods Mol. Biol. 2013, 1023, 21-51.
24. Konzer, A., Ruhs, A., Braun, H., Jungblut, B. et al., Stable isotope labeling in zebrafish allows in vivo monitoring of cardiac morphogenesis. Mol. Cell. Proteomics 2013, 12, 1502-1512.
25. Konzer, A., Ruhs, A., Braun, T., Kruger, M., Global protein quantification of mouse heart tissue based on the SILAC mouse. Methods Mol. Biol. 2013, 1005, 39-52.
26. Silva, J. C., Denny, R., Dorschel, C. A., Gorenstein, M. et al., Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 2005, 77, 2187-2200.
27. Gautier, V., Mouton-Barbosa, E., Bouyssie, D., Delcourt, N. et al., Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol. Cell. Proteomics 2012, 11, 527-539.
28. Duan, X., Young, R., Straubinger, R. M., Page, B. et al., A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J. Proteome Res. 2009, 8, 2838-2850.
29. Gao, J., Friedrichs, M. S., Dongre, A. R., Opiteck, G. J., Guidelines for the routine application of the peptide hits technique. J Am. Soc. Mass Spectrom. 2005, 16, 1231-1238.
30. Liu, H., Sadygov, R. G., Yates, J. R., 3rd, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
31. Griffin, N. M., Yu, J., Long, F., Oh, P. et al., Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 2010, 28, 83-89.
32. Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G. et al., Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 2005, 4, 1487-1502.
33. Asara, J. M., Christofk, H. R., Freimark, L. M., Cantley, L. C., A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen. Proteomics 2008, 8, 994-999.
34. Tu, C., Li, J., Jiang, X., Sheflin, L. et al., Ion current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz Syndrome. Mol. Cell. Proteomics 2013, 12, 3583-3598.
35. Yates, J. R., Ruse, C. I., Nakorchevsky, A., Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 2009, 11, 49-79.
36. Matzke, M. M., Brown, J. N., Gritsenko, M. A., Metz, T. O. et al., A comparative analysis of computational approaches to relative protein quantification using peptide peak intensities in label-free LC-MS proteomics experiments. Proteomics 2013, 13, 493-503.
37. Tu, C., Li, J., Sheng, Q., Zhang, M., Qu, J., Systematic assessment of survey scan and MS2-based abundance strategies for label-free quantitative proteomics using high-resolution MS data. J. Proteome Res. 2014, 13, 2069-2079.
38. Lai, X., Wang, L., Tang, H., Witzmann, F. A., A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS/MS. J. Proteome Res. 2011, 10, 4799-4812.
39. Filiou, M. D., Martins-de-Souza, D., Guest, P. C., Bahn, S., Turck, C. W., To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics 2012, 12, 736-747.
40. Carr, S. A., Anderson, L., Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem. 2008, 54, 1749-1752.
41. Mueller, L. N., Brusniak, M. Y., Mani, D. R., Aebersold, R., An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 2008, 7, 51-61.
42. Zhu, W., Smith, J. W., Huang, C. M., Mass spectrometry-based label-free quantitative proteomics. J. Biomed. Biotechnol. 2010, 2010, 840518.
43. Karp, N. A., Huber, W., Sadowski, P. G., Charles, P. D. et al., Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell. Proteomics 2010, 9, 1885-1897.
44. Merl, J., Ueffing, M., Hauck, S. M., von Toerne, C., Direct comparison of MS-based label-free and SILAC quantitative proteome profiling strategies in primary retinal Muller cells. Proteomics 2012, 12, 1902-1911.
45. Tu, C., Jacob Mammen, M., Li, J., Shen, X. et al., Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients. J. Proteome Res. 2013, 13, 627-639.
46. Vaudel, M., Sickmann, A., Martens, L., Current methods for global proteome identification. Expert Rev. Proteomics 2012, 9, 519-532.
47. Nesvizhskii, A. I., A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J. Proteomics 2010, 73, 2092-2123.
48. Taylor, S. W., Fahy, E., Zhang, B., Glenn, G. M. et al., Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 2003, 21, 281-286.
49. Qu, J., Straubinger, R. M., Improved sensitivity for quantification of proteins using triply charged cleavable isotope-coded affinity tag peptides. Rapid Commun. Mass Spectrom. 2005, 19, 2857-2864.
50. Tu, C., Li, J., Bu, Y., Hangauer, D., Qu, J., An ion-current-based, comprehensive and reproducible proteomic strategy for comparative characterization of the cellular responses to novel anti-cancer agents in a prostate cell model. J. Proteomics 2012, 77, 187-201.
51. Tu, C., Li, J., Young, R., Page, B. J. et al., Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome. Anal. Chem. 2011, 83, 4802-4813.
52. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
53. Fu, Q., Garnham, C. P., Elliott, S. T., Bovenkamp, D. E., Van Eyk, J. E., A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics 2005, 5, 2656-2664.
54. Liu, T., Qian, W. J., Mottaz, H. M., Gritsenko, M. A. et al., Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell. Proteomics 2006, 5, 2167-2174.
55. Gundry, R. L., White, M. Y., Nogee, J., Tchernyshyov, I., Van Eyk, J. E., Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples. Proteomics 2009, 9, 2021-2028.
56. Jaffe, J. D., Keshishian, H., Chang, B., Addona, T. A. et al., Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol. Cell. Proteomics 2008, 7, 1952-1962.
57. Nagaraj, N., Alexander Kulak, N., Cox, J., Neuhauser, N. et al., System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top orbitrap. Mol. Cell. Proteomics 2012, 11, M111.01372.
58. Qu, J., Lesse, A. J., Brauer, A. L., Cao, J. et al., Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses. BMC Microbiol. 2010, 10, 162.
59. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
60. Jullig, M., Hickey, A. J., Chai, C. C., Skea, G. L. et al., Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 2008, 8, 2556-2572.
61. Baseler, W. A., Dabkowski, E. R., Jagannathan, R., Thapa, D. et al., Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304, R553-R565.
62. Diz, A. P., Carvajal-Rodriguez, A., Skibinski, D. O., Multiple hypothesis testing in proteomics: a strategy for experimental work. Mol. Cell. Proteomics 2011, 10, M110 004374.
63. Kim, Y. N., Kim, H. K., Warda, M., Kim, N. et al., Toward a better understanding of preeclampsia: comparative proteomic analysis of preeclamptic placentas. Proteomics Clin. Appl. 2007, 1, 1625-1636.
64. Benjamini, Y. A. H., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 1995, 57, 289-300.
65. Storey, J. D., A direct approach to false discovery rates. J. R. Stat. Soc. Series B 2002, 64, 479-198.
66. Chang, J., Van Remmen, H., Ward, W. F., Regnier, F. E. et al., Processing of data generated by 2-dimensional gel electrophoresis for statistical analysis: missing data, normalization, and statistics. J. Proteome Res. 2004, 3, 1210-1218.
67. Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26, 1367-1372.
68. Margolin, A. A., Ong, S. E., Schenone, M., Gould, R. et al., Empirical Bayes analysis of quantitative proteomics experiments. PLoS One 2009, 4, e7454.
69. Zhang, J., Liem, D. A., Mueller, M., Wang, Y. et al., Altered proteome biology of cardiac mitochondria under stress conditions. J. Proteome Res. 2008, 7, 2204-2214.
70. Baseler, W. A., Dabkowski, E. R., Williamson, C. L., Croston, T. L. et al., Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R186-R200.
71. Dabkowski, E. R., Baseler, W. A., Williamson, C. L., Powell, M. et al., Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am. J. Physiol. Heart. Circ. Physiol. 2010, 299, H529-H540.
72. Bugger, H., Schwarzer, M., Chen, D., Schrepper, A. et al., Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc. Res. 2010, 85, 376-384.
73. Warren, C. M., Geenen, D. L., Helseth, D. L., Jr., Xu, H., Solaro, R. J., Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. J. Proteomics 2010, 73, 1551-1561.
74. Yin, X., Cuello, F., Mayr, U., Hao, Z. et al., Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Mol. Cell. Proteomics 2010, 9, 497-509.
75. Van Hoof, D., Dormeyer, W., Braam, S. R., Passier, R. et al., Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J. Proteome Res. 2010, 9, 1610-1618.
76. Scruggs, S. B., Reisdorph, R., Armstrong, M. L., Warren, C. M. et al., A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain. Mol. Cell. Proteomics 2010, 9, 1804-1818.
77. Fessart, D., Martin-Negrier, M. L., Claverol, S., Thiolat, M. L. et al., Proteomic remodeling of proteasome in right heart failure. J. Mol. Cell Cardiol. 2013, 66C, 41-52.
78. Gregersen, N., Hansen, J., Palmfeldt, J., Mitochondrial proteomics-a tool for the study of metabolic disorders. J. Inherit. Metab. Dis. 2012, 35, 715-726.
79. McDonald, T. G., Van Eyk, J. E., Mitochondrial proteomics. Undercover in the lipid bilayer. Basic Res. Cardiol. 2003, 98, 219-227.
80. Edwards, A. V., White, M. Y., Cordwell, S. J., The role of proteomics in clinical cardiovascular biomarker discovery. Mol. Cell. Proteomics 2008, 7, 1824-1837.
81. Jullig, M., Hickey, A. J., Middleditch, M. J., Crossman, D. J. et al., Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ isobaric tags. Proteomics Clin. Appl. 2007, 1, 565-576.
82. Goudarzi, M., Ross, M. M., Zhou, W., Van Meter, A. et al., Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation. J. Proteome Res. 2011, 10, 3484-3492.
83. Lancaster, T. S., Jefferson, S. J., Hunter, J. C., Lopez, V. et al., Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart. Physiol. Genomics 2012, 44, 957-969.
84. Nguyen, T., Wong, R., Wang, G., Gucek, M. et al., Acute inhibition of GSK causes mitochondrial remodeling. Am. J. Physiol. Heart. Circ. Physiol. 2012, 302, H2439-H2445.
85. Kim, T. Y., Wang, D., Kim, A. K., Lau, E. et al., Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol. Cell. Proteomics 2012, 11, 1586-1594.
86. Weber, K. T., Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 1989, 13, 1637-1652.
87. Spinale, F. G., Zile, M. R., Integrating the myocardial matrix into heart failure recognition and management. Circ. Res. 2013, 113, 725-738.
88. Ghosh, A. K., Vaughan, D. E., Fibrosis: is it a coactivator disease? Front Biosci (Elite Ed) 2012, 4, 1556-1570.
89. Didangelos, A., Yin, X., Mandal, K., Baumert, M. et al., Proteomics characterization of extracellular space components in the human aorta. Mol. Cell. Proteomics 2010, 9, 2048-2062.
90. Didangelos, A., Yin, X., Mandal, K., Saje, A. et al., Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol. Cell. Proteomics 2011, 10, M111 008128.
91. Barallobre-Barreiro, J., Didangelos, A., Schoendube, F. A., Drozdov, I. et al., Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 2012, 125, 789-802.
92. Higuchi, S., Lin, Q., Wang, J., Lim, T. K. et al., Heart extracellular matrix supports cardiomyocyte differentiation of mouse embryonic stem cells. J. Biosci. Bioeng. 2013, 115, 320-325.
93. Edwards, A. V., Cordwell, S. J., White, M. Y., Phosphoproteomic profiling of the myocyte. Circ. Cardiovasc. Genet. 2011, 4, 575.
94. Hart, G. W., Ball, L. E., Post-translational modifications: a major focus for the future of proteomics. Mol. Cell. Proteomics 2013, 12, 3443.
95. Agnetti, G., Husberg, C., Van Eyk, J. E., Divide and conquer: the application of organelle proteomics to heart failure. Circ. Res. 2011, 108, 512-526.
96. Van Eyk, J. E., Lessons from old and new kinases. Circ. Res. 2004, 94, 135-137.
97. Boja, E. S., Phillips, D., French, S. A., Harris, R. A., Balaban, R. S., Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-Orbitrap with high energy collision dissociation. J. Proteome Res. 2009, 8, 4665-4675.
98. Chang, Y. W., Chang, Y. T., Wang, Q., Lin, J. J. et al., Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophy. Mol. Cell. Proteomics 2013, 12, 3094-3107.
99. Scholten, A., Preisinger, C., Corradini, E., Bourgonje, V. J. et al., Phosphoproteomics study based on in vivo inhibition reveals sites of calmodulin-dependent protein kinase II regulation in the heart. J. Am. Heart Assoc. 2013, 2, e000318.
100. Lundby, A., Andersen, M. N., Steffensen, A. B., Horn, H. et al., In vivo phosphoproteomics analysis reveals the cardiac targets of beta-adrenergic receptor signaling. Sci. Signal 2013, 6, rs11.
101. Murray, C. I., Uhrigshardt, H., O'Meally, R. N., Cole, R. N., Van Eyk, J. E., Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol. Cell. Proteomics 2012, 11, M111 013441.
102. Parker, B. L., Palmisano, G., Edwards, A. V., White, M. Y. et al., Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Mol. Cell. Proteomics 2011, 10, M110 006833.
103. Lundby, A., Lage, K., Weinert, B. T., Bekker-Jensen, D. B. et al., Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep. 2012, 2, 419-431.
104. Bousette, N., Chugh, S., Fong, V., Isserlin, R. et al., Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B. Proc. Natl. Acad. Sci. USA 2010, 107, 18481-18486.
105. Li, C., Qiu, Q., Wang, Y., Li, P. et al., Time course label-free quantitative analysis of cardiac muscles of rats after myocardial infarction. Mol. Biosyst. 2014, 10, 505-513.
106. Dubois, E., Fertin, M., Burdese, J., Amouyel, P. et al., Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling. Proteomics Clin. Appl. 2011, 5, 57-66.
107. Gerszten, R. E., Carr, S. A., Sabatine, M., Integration of proteomic-based tools for improved biomarkers of myocardial injury. Clin. Chem. 2010, 56, 194-201.
108. McGregor, E., Dunn, M. J., Proteomics of the heart: unraveling disease. Circ. Res. 2006, 98, 309-321.
109. Canty, J. M., Jr., Suzuki, G., Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J. Mol. Cell. Cardiol. 2012, 52, 822-831.
110. Stastna, M., Van Eyk, J. E., Secreted proteins as a fundamental source for biomarker discovery. Proteomics 2012, 12, 722-735.
111. Hammer, E., Goritzka, M., Ameling, S., Darm, K. et al., Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies. J. Proteome Res. 2011, 10, 2161-2171.
112. Kakimoto, Y., Ito, S., Abiru, H., Kotani, H. et al., Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients. J. Am. Heart Assoc. 2013, 2, e000565.
113. Holland, A., Dowling, P., Zweyer, M., Swandulla, D. et al., Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin. Proteomics 2013, 13, 2312-2323.
114. Chugh, S., Ouzounian, M., Lu, Z., Mohamed, S. et al., Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics 2013, 13, 2324-2334.
115. Jing, L., Parker, C. E., Seo, D., Hines, M. W. et al., Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. Proteomics 2011, 11, 2763-2776.
116. Silbiger, V. N., Luchessi, A. D., Hirata, R. D., Neto, L. G. et al., Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery. Clin. Chim. Acta. 2011, 412, 1086-1093.
117. Juhasz, P., Lynch, M., Sethuraman, M., Campbell, J. et al., Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS. J. Proteome Res. 2011, 10, 34-45.
118. Mebazaa, A., Vanpoucke, G., Thomas, G., Verleysen, K. et al., Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur. Heart J. 2012, 33, 2317-2324.
119. Lewis, G. D., Gerszten, R. E., Toward metabolomic signatures of cardiovascular disease. Circ. Cardiovasc. Genet. 2010, 3, 119-121.
120. Li, M., Gray, W., Zhang, H., Chung, C. H. et al., Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J. Proteome Res. 2010, 9, 4295-4305.
121. Qu, J., Jusko, W. J., Straubinger, R. M., Utility of cleavable isotope-coded affinity-tagged reagents for quantification of low-copy proteins induced by methylprednisolone using liquid chromatography/tandem mass spectrometry. Anal. Chem. 2006, 78, 4543-4552.
122. Schluter, H., Apweiler, R., Holzhutter, H. G., Jungblut, P. R., Finding one's way in proteomics: a protein species nomenclature. Chem. Cent. J. 2009, 3, 11.
123. Chait, B. T., Chemistry. Mass spectrometry: bottom-up or top-down? Science 2006, 314, 65-66.
124. Zhang, J., Guy, M. J., Norman, H. S., Chen, Y. C. et al., Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J. Proteome Res. 2011, 10, 4054-4065.
125. Dong, X., Sumandea, C. A., Chen, Y. C., Garcia-Cazarin, M. L. et al., Augmented phosphorylation of cardiac troponin I in hypertensive heart failure. J. Biol. Chem. 2012, 287, 848-857.
126. Zhang, J., Zhang, H., Ayaz-Guner, S., Chen, Y. C. et al., Phosphorylation, but not alternative splicing or proteolytic degradation, is conserved in human and mouse cardiac troponin T. Biochemistry 2011, 50, 6081-6092.
127. Ryan, C. M., Souda, P., Bassilian, S., Ujwal, R. et al., Post-translational modifications of integral membrane proteins resolved by top-down Fourier transform mass spectrometry with collisionally activated dissociation. Mol. Cell. Proteomics 2010, 9, 791-803.
128. Lange, V., Picotti, P., Domon, B., Aebersold, R., Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 2008, 4, 222.
129. Liebler, D. C., Zimmerman, L. J., Targeted quantitation of proteins by mass spectrometry. Biochemistry 2013, 52, 3797-3806.
130. Shi, T., Fillmore, T. L., Sun, X., Zhao, R. et al., Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl. Acad. Sci. USA 2012, 109, 15395-15400.
131. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M. et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26, 966-968.
132. Shi, T., Su, D., Liu, T., Tang, K. et al., Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 2012, 12, 1074-1092.
133. Pan, S., Aebersold, R., Chen, R., Rush, J. et al., Mass spectrometry based targeted protein quantification: methods and applications. J. Proteome Res. 2009, 8, 787-797.
134. Stergachis, A. B., MacLean, B., Lee, K., Stamatoyannopoulos, J. A., MacCoss, M. J., Rapid empirical discovery of optimal peptides for targeted proteomics. Nat. Methods 2011, 8, 1041-1043.
135. Cao, J., Gonzalez-Covarrubias, V., Straubinger, R. M., Wang, H. et al., A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC-MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver. Anal. Chem. 2010, 82, 2680-2689.
136. Duan, X., Abuqayyas, L., Dai, L., Balthasar, J. P., Qu, J., High-throughput method development for sensitive, accurate, and reproducible quantification of therapeutic monoclonal antibodies in tissues using orthogonal array optimization and nano liquid chromatography/selected reaction monitoring mass spectrometry. Anal. Chem. 2012, 84, 4373-4382.
137. Duan, X., Dai, L., Chen, S. C., Balthasar, J. P., Qu, J., Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis. J. Chromatogr. A 2012, 1251, 63-73.
138. Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B. et al., Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 2004, 3, 235-244.
139. Neubert, H., Muirhead, D., Kabir, M., Grace, C. et al., Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human beta-nerve growth factor. Anal. Chem. 2013, 85, 1719-1726.
140. Keshishian, H., Addona, T., Burgess, M., Mani, D. R. et al., Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2009, 8, 2339-2349.
141. Shi, T., Fillmore, T. L., Gao, Y., Zhao, R. et al., Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis. Anal. Chem. 2013, 85, 9196-9203.
142. Huillet, C., Adrait, A., Lebert, D., Picard, G. et al., Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ) and selected reaction monitoring. Mol. Cell. Proteomics 2012, 11, M111 008235.
143. Jiang, H., Zeng, J., Titsch, C., Voronin, K. et al., Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum. Anal. Chem. 2013, 85, 9859-9867.
144. Ocaña, M. F., Neubert, H., An immunoaffinity liquid chromatography-tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum. Anal. Biochem. 2010, 399, 202-210.
145. Nouri-Nigjeh, E., Zhang, M., Ji, T., Yu, H. et al., Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein. Anal. Chem. 2014, 86, 3575-3584.
146. Kuhn, E., Addona, T., Keshishian, H., Burgess, M. et al., Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 2009, 55, 1108-1117.
147. Domanski, D., Percy, A. J., Yang, J., Chambers, A. G. et al., MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 2012, 12, 1222-1243.
148. Cohen Freue, G. V., Borchers, C. H., Multiple reaction monitoring (MRM): principles and application to coronary artery disease. Circ. Cardiovasc. Genet. 2012, 5, 378.
149. Cohen Freue, G. V., Meredith, A., Smith, D., Bergman, A. et al., Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation. PLoS Comput. Biol. 2013, 9, e1002963.
150. Kristensen, L. P., Larsen, M. R., Mickley, H., Saaby, L. et al., Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. J. Proteomics 2014, 101, 141-153.
151. Lam, M. P., Scruggs, S. B., Kim, T. Y., Zong, C. et al., An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J. Proteomics 2012, 75, 4602-4609.
152. Lam, M. P., Lau, E., Scruggs, S. B., Wang, D. et al., Site-specific quantitative analysis of cardiac mitochondrial protein phosphorylation. J. Proteomics 2013, 81, 15-23.
153. Zhang, P., Kirk, J. A., Ji, W., dos Remedios, C. G. et al., Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation 2012, 126, 1828-1837.
154. Kooij, V., Zhang, P., Piersma, S. R., Sequeira, V. et al., PKCalpha-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis. PLoS One 2013, 8, e74847.
155. Aebersold, R., Burlingame, A. L., Bradshaw, R. A., Western blots versus selected reaction monitoring assays: time to turn the tables? Mol. Cell. Proteomics 2013, 12, 2381-2382.
156. Fu, Q., Schoenhoff, F. S., Savage, W. J., Zhang, P., Van Eyk, J. E., Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin. Appl. 2010, 4, 271-284.
157. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M. et al., The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39, D561-D568.
158. Black, K. M., Barnett, R. J., Bhasin, M. K., Daly, C. et al., Microarray and proteomic analysis of the cardioprotective effects of cold blood cardioplegia in the mature and aged male and female. Physiol. Genomics 2012, 44, 1027-1041.
159. Langley, S. R., Dwyer, J., Drozdov, I., Yin, X., Mayr, M., Proteomics: from single molecules to biological pathways. Cardiovasc. Res. 2013, 97, 612-622.
160. Hebert, A. S., Richards, A. L., Bailey, D. J., Ulbrich, A. et al., The one hour yeast proteome. Mol. Cell. Proteomics 2014, 13, 339-347.